Mild side effects reported during or after glutathione IV infusions include: Nausea and vomiting occur in some individuals, particularly at higher doses or faster infusion rates
Insulin resistance can result in the development of type 2 diabetes
G6PD catalyzes the rate-limiting step in the pentose phosphate pathway, which provides nucleotide precursors for DNA replication as well as cytosolic reducing equivalents of the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH)
GHK-Cu helps counter this by: Reducing inflammatory signaling Supporting antioxidant defenses Protecting skin from environmental damage This makes it especially appealing for patients with sensitive or compromised skin
Gen Comp Endoc 148:273281 Kellner R, Mermet J-M, Otto M, Valcarcel M, Widmer HM (2004) Analytical chemistry
doi: 10.1016/j.freeradbiomed.2014.05.004